April R. Giles

668 total citations
10 papers, 456 citations indexed

About

April R. Giles is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, April R. Giles has authored 10 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in April R. Giles's work include Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (4 papers) and CAR-T cell therapy research (4 papers). April R. Giles is often cited by papers focused on Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (4 papers) and CAR-T cell therapy research (4 papers). April R. Giles collaborates with scholars based in United States, France and Egypt. April R. Giles's co-authors include James M. Wilson, L. Govindasamy, Michael J. Castle, Zachary T. Gershenson, Erika L.F. Holzbaur, John H. Wolfe, Suryanarayan Somanathan, Jenessa B. Smith, Josh Tycko and Jesse L. Rodriguez and has published in prestigious journals such as Journal of Virology, Frontiers in Immunology and Molecular Therapy.

In The Last Decade

April R. Giles

8 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
April R. Giles United States 7 310 294 73 68 55 10 456
Christina Rauschhuber Germany 8 412 1.3× 327 1.1× 73 1.0× 59 0.9× 24 0.4× 10 548
Rajani Shelke United States 7 341 1.1× 230 0.8× 33 0.5× 38 0.6× 37 0.7× 8 448
John Monahan Japan 10 350 1.1× 276 0.9× 43 0.6× 118 1.7× 78 1.4× 13 555
Erin Bote United States 6 241 0.8× 218 0.7× 39 0.5× 69 1.0× 23 0.4× 12 357
Maren Haase Germany 4 248 0.8× 170 0.6× 33 0.5× 56 0.8× 20 0.4× 10 389
Peiyin Wang United States 7 230 0.7× 161 0.5× 45 0.6× 39 0.6× 29 0.5× 11 378
Nathalie Dutheil France 11 255 0.8× 214 0.7× 33 0.5× 104 1.5× 26 0.5× 19 562
Sarah C. Nicolson United States 8 368 1.2× 348 1.2× 52 0.7× 28 0.4× 50 0.9× 9 467
Giridhar Murlidharan United States 7 230 0.7× 194 0.7× 15 0.2× 92 1.4× 21 0.4× 11 375
Brian Cleaver United States 13 371 1.2× 279 0.9× 47 0.6× 36 0.5× 41 0.7× 19 663

Countries citing papers authored by April R. Giles

Since Specialization
Citations

This map shows the geographic impact of April R. Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April R. Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April R. Giles more than expected).

Fields of papers citing papers by April R. Giles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by April R. Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April R. Giles. The network helps show where April R. Giles may publish in the future.

Co-authorship network of co-authors of April R. Giles

This figure shows the co-authorship network connecting the top 25 collaborators of April R. Giles. A scholar is included among the top collaborators of April R. Giles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April R. Giles. April R. Giles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Firnberg, Elad, Sonia Tejada, Samantha A. Yost, et al.. (2025). Directed evolution of liver-detargeted AAV vectors for systemic gene delivery to skeletal muscle and heart. Molecular Therapy — Methods & Clinical Development. 33(4). 101571–101571.
2.
Giles, April R., Martin Lock, Shu‐Jen Chen, et al.. (2023). Significant Differences in Capsid Properties and Potency Between Adeno-Associated Virus Vectors Produced in Sf9 and HEK293 Cells. Human Gene Therapy. 34(19-20). 1003–1021. 14 indexed citations
3.
Hollidge, Bradley S., April R. Giles, Andrew C. Mercer, et al.. (2022). Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors. Frontiers in Neurology. 13. 1051559–1051559. 14 indexed citations
4.
Giles, April R., Roberto Calcedo, Anna P. Tretiakova, & James M. Wilson. (2020). Isolating Human Monoclonal Antibodies Against Adeno-Associated Virus From Donors With Pre-existing Immunity. Frontiers in Immunology. 11. 1135–1135. 6 indexed citations
5.
Somanathan, Suryanarayan, et al.. (2019). TLR9 signaling mediates adaptive immunity following systemic AAV gene therapy. Cellular Immunology. 346. 103997–103997. 47 indexed citations
6.
Giles, April R., Joshua J. Sims, Kevin B. Turner, et al.. (2018). Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector Function. Molecular Therapy. 26(12). 2848–2862. 90 indexed citations
7.
Giles, April R., L. Govindasamy, Suryanarayan Somanathan, & James M. Wilson. (2018). Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors. Journal of Virology. 92(20). 33 indexed citations
8.
Castle, Michael J., Zachary T. Gershenson, April R. Giles, Erika L.F. Holzbaur, & John H. Wolfe. (2014). Adeno-Associated Virus Serotypes 1, 8, and 9 Share Conserved Mechanisms for Anterograde and Retrograde Axonal Transport. Human Gene Therapy. 25(8). 705–720. 106 indexed citations
9.
Bryant, Laura, April R. Giles, Christian Hinderer, et al.. (2013). Lessons Learned from the Clinical Development and Market Authorization of Glybera. PubMed. 24(2). 55–64. 145 indexed citations
10.
Dray, James F., April R. Giles, Michael F. Kelley, & Ramaswamy Chandramouli. (2006). SP 800-96. PIV Card to Reader Interoperability Guidelines. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Rauschhuber Breakdown of academic impact, for papers by Rajani Shelke Breakdown of academic impact, for papers by John Monahan Breakdown of academic impact, for papers by Erin Bote Breakdown of academic impact, for papers by Maren Haase Breakdown of academic impact, for papers by Peiyin Wang Breakdown of academic impact, for papers by Nathalie Dutheil Breakdown of academic impact, for papers by Sarah C. Nicolson Breakdown of academic impact, for papers by Giridhar Murlidharan Breakdown of academic impact, for papers by Brian Cleaver
Rankless by CCL
2026